Cholesterol changes in perimenopause: what rises, when, and what to do

Cholesterol typically rises in perimenopause, and the timing is specific: LDL cholesterol climbs fastest in the year before and the year after your final period. The increase is driven by the transition itself, not only by age or weight. It is a good reason to get a lipid panel in your mid to late 40s and to know where you stand before the jump.

What changes and when

The clearest evidence comes from SWAN, the Study of Women’s Health Across the Nation, which measured lipids every year in a multiethnic group of US women. Among 1,054 women who reached a natural final menstrual period without prior hormone therapy, researchers compared two explanations: steady change with age, or a step change tied to menopause.

Only three markers fit the menopause pattern: total cholesterol, LDL cholesterol and apolipoprotein B (apoB, a measure of the number of cholesterol-carrying particles such as LDL). All three rose sharply within one year on either side of the final period. The pattern was the same across African American, Chinese, Japanese, Hispanic and white women. Blood pressure, glucose and triglycerides, in contrast, changed in step with age.

Average yearly change (mg/dL)	More than 12 months before final period	Within 12 months of final period	More than 12 months after
Total cholesterol	+3.0	+6.5	-0.2
LDL cholesterol	+1.6	+5.2	+0.1
Apolipoprotein B	+0.7	+3.2	-0.4

The starting LDL in this group averaged about 114 mg/dL. The rise is modest on average, but it adds to wherever you started, and it lands in the decade when other risks are also climbing. The authors noted that even lipid levels in the normal range during the transition predict later coronary calcium and artery wall thickening, and concluded that monitoring lipids in perimenopausal women should improve prevention.

HDL is not the safety net it seems. HDL (“good”) cholesterol tends to rise before the final period. But in a SWAN substudy of 213 women, a larger rise in HDL across the transition was linked to faster thickening of the carotid artery wall. The researchers suggest that HDL may become less protective during menopause, so a high HDL should not be used to offset a high LDL.

Lipoprotein(a). Lp(a) is a mostly inherited particle that raises heart risk. A 2023 meta-analysis found levels about 3.8 mg/dL higher in postmenopausal than in premenopausal women, but no difference when the groups were matched for age, so menopause may raise Lp(a) slightly or the difference may reflect aging.

Reading your lipid panel

A standard panel reports total cholesterol, LDL, HDL and triglycerides; non-HDL cholesterol is total minus HDL. The 2026 ACC/AHA/multisociety dyslipidemia guideline, which replaced the 2018 cholesterol guideline, adds two points relevant to midlife women:

• Lipoprotein(a) once in a lifetime. Every adult should have it measured at least once. A level of about 125 nmol/L (50 mg/dL) or higher is treated as a risk enhancer.
• Apolipoprotein B can refine the picture, particularly when triglycerides are high, with diabetes, or when LDL is already low.

How treatment is decided under the 2026 guideline

The guideline replaced the older Pooled Cohort Equations with the PREVENT equations and widened risk estimation to adults aged 30 to 79. Some situations call for a statin regardless of the calculation.

Situation	General approach
LDL 190 mg/dL or higher, diabetes, stage 3 or worse chronic kidney disease, or HIV	Statin recommended without needing a risk score
10-year risk under 3% (low)	Lifestyle first; a statin may be considered if LDL is 160 to 189 mg/dL or 30-year risk is 10% or more
3% to under 5% (borderline)	A moderate-intensity statin is reasonable, especially with risk enhancers
5% to under 10% (intermediate)	A statin is generally recommended
10% or more (high)	High-intensity statin recommended
LDL under 70 mg/dL	Statins not recommended for primary prevention

The guideline also lists risk enhancers that can tip borderline and intermediate decisions, among them premature or early menopause, pregnancy complications such as preeclampsia, an elevated Lp(a) and high-sensitivity C-reactive protein. When uncertainty remains, a coronary artery calcium scan can help in women 45 and older. The guideline also brings back LDL goals, with lower targets as risk rises.

These changes expand eligibility. An analysis of national survey data in JAMA estimated that 87.5 million US adults aged 30 to 79, or 56.6%, are statin-eligible under the 2026 guideline, including 21.5 million newly eligible people who are mostly younger and at lower risk.

The US Preventive Services Task Force, using the older calculator, recommends a statin for adults 40 to 75 with at least one risk factor (high cholesterol, diabetes, high blood pressure or smoking) and a 10-year risk of 10% or more, and selective use at 7.5% to under 10%. Different thresholds reflect different calculators, so ask which one your clinician used.

What you can do

• Get a baseline. A lipid panel in your 40s, before the final period, gives you a reference point. Ask for Lp(a) if it has never been measured.
• Recheck around the transition. If your periods are becoming irregular, a repeat panel within a few years will catch the jump.
• Eat for LDL. Less saturated fat and more fiber, legumes, nuts and olive oil is the pattern behind the Mediterranean diet. Omega-3 supplements mainly affect triglycerides rather than LDL.
• Move and lift. Regular activity and strength training help weight and body composition.
• Consider medication when your risk calls for it. Statins are inexpensive, well studied and the first choice when lipid-lowering drugs are recommended.

Where hormone therapy fits

Hormone therapy is prescribed for symptoms such as hot flashes, not to treat cholesterol, and it is not approved to prevent heart disease. If you use it, your lipid targets and statin decisions follow the same rules as for anyone else. For context on risks and timing, see is hormone therapy safe? and HRT in perimenopause vs menopause.

When to see a clinician

Ask for a lipid panel if you have not had one in five years, if your LDL was borderline before, or if you had early menopause, preeclampsia or gestational diabetes. An LDL of 190 mg/dL or higher, or a parent or sibling with early heart disease, warrants a closer look for an inherited cholesterol disorder. Read more about the bigger picture in menopause and heart disease, or find a clinician through our directory.